Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 358 (9283) , 702-710
- https://doi.org/10.1016/s0140-6736(01)05837-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antithrombotic and Thrombolytic Therapy for Ischemic StrokeChest, 1998
- Low molecular weight heparin in acute strokeExpert Opinion on Investigational Drugs, 1998
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokePublished by Elsevier ,1997
- European Strategies for Early Intervention in Stroke (Part 1 of 2)Cerebrovascular Diseases, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Antithrombotic Therapy for Cerebrovascular DisordersChest, 1995
- Treatment of Deep Venous Thrombosis With Low-Molecular-Weight HeparinsArchives of internal medicine (1960), 1995
- Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Low molecular weight heparin in prevention of perioperative thrombosis.BMJ, 1992